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Abstract
Finally, we have addressed some relevant findings on the importance of having well-defined synthetic strategies
developed for the generation of MNPs, with a focus on particle formation mechanism and recent modifications
made on the preparation of monodisperse samples of relatively large quantities not only with similar physical
features, but also with similar crystallochemical characteristics. Then, different methodologies for the
functionalization of the prepared MNPs together with the characterization techniques are explained. Theorical
views on the magnetism of nanoparticles are considered.
Keywords: magnetic nanoparticles, synthetic routes, biomedical applications, functionalization techniques,
characterization
Introduction
Nanoscience is one of the most important research in
modern science. Nanotechnology is beginning to allow
scientists, engineers, chemists, and physicians to work at
the molecular and cellular levels to produce important
advances in the life sciences and healthcare. The use of
nanoparticle [NP] materials offers major advantages due
to their unique size and physicochemical properties.
Because of the widespread applications of magnetic
nanoparticles [MNPs] in biotechnology, biomedical,
material science, engineering, and environmental areas,
much attention has been paid to the synthesis of differ-
ent kinds of MNPs [1-3].
Real uses of nanostructured materials in life sciences
are uncommon at the present time. However, the excel-
lent properties of these materials provide a very promis-
ing future for their use in this field [4-7]. Nanoclusters
are ultrafine particles of nanometer dimensions located
between molecules and microscopic structures (micron
size). Viewed as materials, they are so small that they
exhibit characteristics that are not observed in larger
structures (even 100 nm); viewed as molecules, they are
so large that they provide access to realms of quantum
behavior that are not otherwise accessible. In this size,
many recent advances have been made in biology,
chemistry, and physics [8-11]. The preparation of mono-
disperse-sized nanocrystals is very important because
the properties of these nanocrystals depend strongly on
their dimensions [12,13]. The preparation of monodis-
perse-sized nanocrystals with controllable sizes is very
important to characterize the size-dependent physico-
chemical properties of nanocrystals [14-16].
Industrial applications of magnetic nanoparticles cover
a broad spectrum of magnetic recording media and bio-
medical applications, for example, magnetic resonance
contrast media and therapeutic agents in cancer treat-
ment [17,18]. Each potential application of the magnetic
nanoparticles requires having different properties. For
example, in data storage applications, the particles need
to have a stable, switchable magnetic state to represent
bits of information that are not affected by temperature
fluctuations.
For biomedical uses, the application of particles that
present superparamagnetic behavior at room tempera-
ture is preferred [19-21]. Furthermore, applications in
therapy and biology and medical diagnosis require the
magnetic particles to be stable in water at pH 7 and in a
physiological environment. The colloidal stability of this
fluid will depend on the charge and surface chemistry,
which give rise to both steric and coulombic repulsions
and also depend on the dimensions of the particles,
which should be sufficiently small so that precipitation
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r e s t r i c t i o n st ot h ep o s s i b l ep a r t i c l e sc o u l db eu s e df o r
biomedical applications (in vivo or in vitro applications).
For in vivo applications, the magnetic nanoparticles
must be encapsulated with a biocompatible polymer
during or after the preparation process to prevent
changes from the original structure, the formation of
large aggregates, and biodegradation when exposed to
the biological system. The nanoparticle coated with
polymer will also allow binding of drugs by entrapment
on the particles, adsorption, or covalent attachment
[23-25]. The major factors, which determine toxicity
and the biocompatibility of these materials, are the nat-
ure of the magnetically responsive components, such as
magnetite, iron, nickel, and cobalt, and the final size of
the particles, their core, and the coatings. Iron oxide
nanoparticles such as magnetite (Fe3O4) or its oxidized
form maghemite (g-Fe2O3) are by far the most com-
monly employed nanoparticles for biomedical applica-
tions. Highly magnetic materials such as cobalt and
nickel are susceptible to oxidation and are toxic; hence,
they are of little interest [26-28]. Moreover, the major
advantage of using particles of sizes smaller than 100
nm is their higher effective surface areas, lower sedi-
mentation rates, and improved tissular diffusion [29-31].
Another advantage of using nanoparticles is that the
magnetic dipole-dipole interactions are significantly
reduced because they scale as r6 [32]. Therefore, for in
vivo biomedical applications, magnetic nanoparticles
must be made of a non-toxic and non-immunogenic
material, with particle sizes small enough to remain in
the circulation after injection and to pass through the
capillary systems of organs and tissues, avoiding vessel
embolism. They must also have a high magnetization so
that their movement in the blood can be controlled
with a magnetic field and so that they can be immobi-
lized close to the targeted pathologic tissue [33-35]. For
in vitro applications, composites consisting of superpara-
magnetic nanocrystals dispersed in submicron diamag-
netic particles with long sedimentation times in the
absence of a magnetic field can be used because the size
restrictions are not so severe as in in vivo applications.
The major advantage of using diamagnetic matrixes is
that the superparamagnetic composites can be easily
prepared with functionality.
In almost all uses, the synthesis method of the nano-
materials represents one of the most important chal-
lenges that will determine the shape, the size
distribution, the particle size, the surface chemistry of
the particles, and consequently their magnetic properties
[36-38]. Ferri- and ferromagnetic materials such as
Fe3O4 and some alloys have irregular particle shape
when obtained by grinding bulk materials but can have
a spherical shape when synthesized by plasma
atomization, wet chemistry,o rf r o mt h eg a sp h a s e sa n d
aerosol. Also, depending on the mechanism of forma-
tion, spherical particles obtained in a solution can be
crystalline or amorphous if they result from a disordered
or ordered aggregation of crystallites, respectively. In
addition, the synthesis method determines to a great
extent the degree of structural defects or impurities in
the particle as well as the distribution of such defects
within the particle, therefore, determining its magnetic
behavior [39,40]
Recently, many attempts have been made to develop
techniques and processes that would yield ‘monodis-
persed colloids’ consisting of uniform nanoparticles both
in size and shape [41-43]. In these systems, the entire
uniform physicochemical properties directly reflect the
properties of each constituent particle. Monodispersed
colloids have been exploited in fundamental research
and as models in the quantitative assessment of proper-
ties that depend on the particle size and shape. In addi-
tion, it has become evident that the reproducibility and
quality of commercial products can be more readily
achieved by starting with well-defined powders of
known properties. In this way, these powders have
found uses in photography, inks in printing, catalysis,
ceramic, and especially in medicine.
Magnetic nanoparticles show remarkable new phe-
nomena such as high field irreversibility, high saturation
field, superparamagnetism, extra anisotropy contribu-
tions, or shifted loops after field cooling. These phe-
nomena arise from narrow and finite-size effects and
surface effects that dominate the magnetic behavior of
individual nanoparticles [44]. Frenkel and Dorfman [45]
were the first to predict that a particle of ferromagnetic
material, below a critical particle size (<15 nm for the
common materials), would consist of a single magnetic
domain, i.e., a particle that is in a state of uniform mag-
netization at any field. The magnetization behavior of
these particles above a certain temperature, i.e., the
blocking temperature, is identical to that of atomic para-
magnets (superparamagnetism) except that large sus-
ceptibilities and, thus, an extremely large moment are
involved [46].
The first part of this review is concerned with the
physical properties of magnetic nanoparticles and their
magnetometric property. The second part deals with the
possible use of magnetic nanoparticles for biomedical
application with special emphasis on the advantage of
using nanoparticles with respect to microparticles and
on some of the recent environmental, industrial, biologi-
cal, and analytical applications of MNPs. The third part
deals with the different methods described in the biblio-
graphy that are capable of producing these magnetic
nanoparticles with a very narrow particle size distribu-
tion, mainly based on magnetite or maghemite iron
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the most relevant preparation effects on the magnetic
properties and structure of the magnetic nanoparticles.
Preparation Methods
During the last few years, a large portion of the pub-
lished articles about MNPs have described efficient
routes to attain shape-controlled, highly stable, and nar-
row size distribution MNPs. Up to date, several popular
methods including co-precipitation, microemulsion,
thermal decomposition, solvothermal, sonochemical,
microwave assisted, chemical vapour deposition, com-
bustion synthesis, carbon arc, laser pyrolysis synthesis
have been reported for synthesis of MNPs.
Physical properties of magnetic nanoparticles
Magnetic effects are caused by movements of particles
that have both mass and electric charges. These particles
are electrons, holes, protons, and positive and negative
ions. A spinning electric-charged particle creates a mag-
netic dipole, so-called magneton. In ferromagnetic mate-
rials, magnetons are associated in groups. A magnetic
domain (also called a Weiss domain) refers to a volume
of ferromagnetic material in which all magnetons are
aligned in the same direction by the exchange forces.
This concept of domains distinguishes ferromagnetism
from paramagnetism. The domain structure of a ferro-
magnetic material determines the size dependence of its
magnetic behavior. When the size of a ferromagnetic
material is reduced below a critical value, it becomes a
single domain. Fine particle magnetism comes from size
effects, which are based on the magnetic domain struc-
ture of ferromagnetic materials. It assumes that the state
of lowest free energy of ferromagnetic particles has uni-
form magnetization for particles smaller than a certain
critical size and has nonuniform magnetization for lar-
ger particles. The former ones are referred to as single
domain particles, while the latter are called multidomain
particles [49,50]. According to the magnetic domain
theory, the critical size of the single domain is affected
by several factors including the value of the magnetic
saturation, the strength of the crystal anisotropy and
exchange forces, surface or domain-wall energy, and the
shape of the particles. The reaction of ferromagnetic
materials on an applied field is well described by a hys-
teresis loop, which is characterized by two main para-
meters: remanence and coercivity. The latter is related
to the ‘thickness’ of the curve. Dealing with fine parti-
cles, the coercivity is the single property of most inter-
est, and it is strongly size-dependent. It has been found
that as the particle size is reduced, the coercivity
increases to a maximum and then decreases toward zero
(Figure 1).
When the size of single-domain particles further
decreases below a critical diameter, the coercivity
becomes zero, and such particles become superparamag-
netic. Superparamagnetism is caused by thermal effects.
In superparamagnetic particles, thermal fluctuations are
strong enough to spontaneously demagnetize a pre-
viously saturated assembly; therefore, these particles
have zero coercivity and have no hysteresis. Nanoparti-
cles become magnetic in the presence of an external
magnet, but revert to a nonmagnetic state when the
external magnet is removed. This avoids an ‘active’
behavior of the particles when there is no applied field.
Introduced in the living systems, particles are ‘magnetic’
only in the presence of an external field, which gives
them unique advantage in working in biological environ-
ments. There are a number of crystalline materials that
exhibit ferromagnetism, among others Fe, Co, or Ni.
Since ferrite oxide-magnetite (Fe3O4) is the most mag-
netic of all the naturally occurring minerals on earth, it
is widely used in the form of superparamagnetic nano-
particles for all sorts of biological applications [51-53].
Magnetic property (magnetic behavior)
Materials are classified by their response to an externally
applied magnetic field. Descriptions of orientations of
Figure 1 Schematic illustration of the coercivity-size relations of small particles.
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ent forms of magnetism observed in nature. Five basic
types of magnetism can be described: diamagnetism,
paramagnetism, ferromagnetism, antiferromagnetism,
and ferrimagnetisms. In the presence of an externally
applied magnetic field, the atomic current loops created
by the orbital motion of electrons respond to oppose
the applied field. All materials display this type of weak
repulsion to a magnetic field known as diamagnetism.
However, diamagnetism is very weak, and therefore, any
other form of magnetic behavior that a material may
possess usually overpowers the effects of the current
loops. In terms of the electronic configuration of the
materials, diamagnetism is observed in materials with
filled electronic subshells where the magnetic moments
are paired and overall cancel each other. Diamagnetic
materials have a negative susceptibility (c <0 )a n d
weakly repel an applied magnetic field (e.g., quartz
SiO2). The effects of these atomic current loops are
overcome if the material displays a net magnetic
moment or has a long-range ordering of its magnetic
moments [54-56]. All other types of magnetic behaviors
are observed in materials that are at least partially
attributed to unpaired electrons in their atomic shells,
o f t e ni nt h e3 d or 4f shells of each atom. Materials
whose atomic magnetic moments are uncoupled display
paramagnetism; thus, paramagnetic materials have
moments with no long-range order, and there is a small
positive magnetic susceptibility (c ≈ 0), e.g., pyrite
[57-59]. Materials that possess ferromagnetism have
aligned atomic magnetic moments of equal magnitude,
and their crystalline structures allow for direct coupling
interactions between the moments, which may strongly
enhance the flux density (e.g., Fe, Ni, and Co). Further-
more, the aligned moments in ferromagnetic materials
can confer a spontaneous magnetization in the absence
of an applied magnetic field. Materials that retain per-
manent magnetization in the absence of an applied field
are known as hard magnets. Materials having atomic
magnetic moments of equal magnitude that are
arranged in an antiparallel fashion display antiferromag-
netism (e.g., troilite FeS). The exchange interaction cou-
ples the moments in such a way that they are
antiparallel, therefore, leaving a zero net magnetization
[60]. Above the Néel temperature, thermal energy is suf-
ficient to cause the equal and oppositely aligned atomic
moments to randomly fluctuate, leading to a disappear-
ance of their long-range order. In this state, the materi-
als exhibit paramagnetic behavior. Ferrimagnetism is a
property exhibited by materials whose atoms or ions
tend to assume an ordered but nonparallel arrangement
in a zero applied field below a certain characteristic
temperature known as the Néel temperature (e.g., Fe3O4
and Fe3S4). In the usual case, within a magnetic domain,
a substantial net magnetization results from the antipar-
allel alignment of neighboring non-equivalent sublat-
tices. The macroscopic behavior is similar to
ferromagnetism. Above the Néel temperature, the sub-
stance becomes paramagnetic (Figure 2) [61,62].
Applications
Industrial applications
Magnetic iron oxides are commonly used as synthetic
pigments in ceramics, paints, and porcelain. Magnetic
encapsulates may find very important uses in many
areas of life and also in various branches of industry.
Such materials are interesting from both points of the
fundamental study of materials science as well as their
applications [63,64]. Hematite and magnetite have been
applied as catalysts for a number of important reactions,
such as the preparation of NH3, the desulfurization of
natural gas, and the high-temperature water-gas shift
reaction. Other reactions include the Fishere-Tropsch
synthesis for hydrocarbons, the dehydrogenation of
ethylbenzene to styrene, the oxidation of alcohols, and
the large-scale synthesis of butadiene [65-67].
Figure 2 Magnetization behavior of ferromagnetic and
superparamagnetic NPs under an external magnetic field.( a)
Under an external magnetic field, domains of a ferromagnetic NP
align with the applied field. The magnetic moment of single
domain superparamagnetic NPs aligns with the applied field. In the
absence of an external field, ferromagnetic NPs will maintain a net
magnetization, whereas superparamagnetic NPs will exhibit no net
magnetization due to rapid reversal of the magnetic moment. (b)
Relationship between NP size and the magnetic domain structures.
Ds and Dc are the ‘superparamagnetism’ and ‘critical’ size
thresholds.
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Biomedical applications of magnetic nanoparticles can
be classified according to their application inside or out-
side the body (in vivo, in vitro). For in vitro applications,
the main use is in diagnostic separation, selection, and
magnetorelaxometry, while for in vivo applications, it
could be further separated in therapeutic (hyperthermia
and drug-targeting) and diagnostic applications (nuclear
magnetic resonance [NMR] imaging) [68-70].
In vivo applications
Two major factors play an important role for the in vivo
uses of these particles: size and surface functionality.
Even without targeting surface ligands, superparamag-
netic iron oxide NP [SPIOs] diameters greatly affect in
vivo biodistribution. Particles with diameters of 10 to 40
nm including ultra-small SPIOs are important for pro-
longed blood circulation; they can cross capillary walls
and are often phagocytosed by macrophages which traf-
fic to the lymph nodes and bone marrow [71].
1. Therapeutic applications. Hyperthermia: Placing
superparamagnetic iron oxide in altering current
[AC] magnetic fields randomly flips the magnetiza-
tion direction between the parallel and antiparallel
orientations, allowing the transfer of magnetic
energy to the particles in the form of heat, a prop-
erty that can be used in vivo to increase the tem-
perature of tumor tissues to destroy the pathological
cells by hyperthermia. Tumor cells are more sensi-
tive to a temperature increase than healthy ones
[72,73]. In past studies, magnetite cationic liposomal
nanoparticles and dextran-coated magnetite [74]
have been shown to effectively increase the tempera-
ture of tumor cells for hyperthermia treatment in
cell irradiation. This has been proposed to be one of
the key approaches to successful cancer therapy in
the future [75]. The advantage of magnetic
hyperthermia is that it allows the heating to be
restricted to the tumor area. Moreover, the use of
subdomain magnetic particles (nanometer-sized) is
preferred instead multidomain (micron-sized) parti-
cles because nanoparticles absorb much more power
at tolerable AC magnetic fields [76,77] which is
strongly dependent on the particle size and shape,
and thus, having well-defined synthetic routes able
to produce uniform particles is essential for a rigor-
ous control in temperature.
2. Drug delivery. Drug targeting has emerged as one
of the modern technologies for drug delivery. The
possibilities for the application of iron oxide mag-
netic nanoparticles in drug targeting have drastically
increased in recent years [78]. MNPs in combination
with an external magnetic field and/or magnetizable
implants allow the delivery of particles to the desired
target area, fix them at the local site while the medi-
cation is released, and act locally (magnetic drug tar-
geting) [79]. Transportation of drugs to a specific
site can eliminate side effects and also reduce the
dosage required. The surfaces of these particles are
generally modified with organic polymers and inor-
ganic metals or oxides to make them biocompatible
and suitable for further functionalization by the
attachment of various bioactive molecules [80,81].
The process of drug localization using magnetic
delivery systems is based on the competition
between the forces exerted on the particles by the
blood compartment and the magnetic forces gener-
ated from the magnet.
3. Diagnostic applications
a. NMR imaging. The development of the NMR
imaging technique for clinical diagnosis has
prompted the need for a new class of pharma-
ceuticals, so-called magneto-pharmaceuticals.
These drugs must be administered to a patient
in order to (1) enhance the image contrast
between the normal and diseased tissue and/or
(2) indicate the status of organ functions or
blood flow.
In vitro applications
1. Diagnostic applications
a. Separation and selection. At present, consider-
able attention is being paid to solid-phase extrac-
tion [SPE] as a way to isolate and preconcentrate
desired components from a sample matrix. SPE
is a routine extraction method for determining
trace-level contaminants in environmental sam-
ples. Recently, nanometer-sized particles (nano-
particles, NPs) have gained rapid and substantial
progress and have a significant impact on sample
extraction. SPE offers an excellent alternative to
the conventional sample concentration methods,
such as liquid-liquid extraction [82-84]. The
separation and preconcentration of the substance
from large volumes of solution can be highly
time consuming when using standard column
SPE, and it is in this field where the use of mag-
netic or magnetizable adsorbents called magnetic
solid-phase extraction [MSPE] gains importance.
In this procedure, the magnetic adsorbent is
added to a solution or suspension containing the
target. This is adsorbed onto the magnetic adsor-
bent, and then, the adsorbent with the adsorbed
target is recovered from the suspension using an
appropriate magnetic separator. For separation
and selection, the advantage of using magnetic
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that we can prepare suspensions that are stable
against sedimentation in the absence of an
applied magnetic field. The applicability of iron
oxide magnetic nanoparticles in MSPE is clearly
evidenced by the fact that it already exists in the
market companies (DYNAL Biotech) that com-
mercialize these products (Figure 3).
b. Magnetorelaxometry. It was introduced as a
method for the evaluation of immunoassays [85].
Magnetorelaxometry measures the magnetic visc-
osity, i.e., the relaxation of the net magnetic
moment of a system of magnetic nanoparticles
after removal of a magnetic field [86]. There are
t w od i f f e r e n tr e l a x a t i o nm e c h a n i s m s .F i r s t ,t h e
internal magnetization vector of a nanoparticle
relaxes in the direction of the easy axis inside the
core; this is called Néel relaxation [87]. Second,
particles accomplish rotational diffusion in a car-
rier liquid, called Brownian relaxation [88]. Néel
and Brownian relaxation can be distinguished by
their different relaxation times [89]. Furthermore,
Brownian relaxation can take place only in
liquids, whereas Néel relaxation does not depend
on the dispersion of the nanoparticles. The fact
that magnetorelaxometry depends on the core
size, the hydrodynamic size, and the anisotropy
allows this technique to distinguish between the
free and bound conjugates by their different
magnetic behavior and therefore can be used as
an analytical tool for the evaluation of immu-
noassays [90]. For this application, the benefits of
reducing the particle size to the nanometer size
are similar to those described for separation and
selection applications.
c. Magnetic resonance imaging. At the boundary
between nanomaterials and medical diagnostics,
superparamagnetic iron oxide NPs are proving to
be a class of novel probes useful for in vitro and
in vivo cellular and molecular imaging. Superpar-
amagnetic contrast agents have an advantage of
producing an enhanced proton relaxation in
magnetic resonance imaging [MRI] in compari-
son with paramagnetic ones. Consequently, less
amounts of a SPIO agent are needed to dose the
human body than a paramagnetic one. To apply
t h em a g n e t i cf l u i d st oaM R Ic o n t r a s ta g e n t ,a
SPIO should be dispersed into a biocompatible
and biodegradable carrier. Recently, Muller et al.
[91] comprehensively reviewed the applications
of super paramagnetic iron oxide NPs as a con-
trast agent. However, MRIs are not convenient
for in situ monitoring. Thus, a sensitive and sim-
ple technique for in situ monitoring of the NPs
in living cells is desirable. Compared to conven-
tional organic fluorescence probes, advantages of
the nanometer-sized fluorescence probes mainly
include their higher photostability and stronger
fluorescence. The main problem in cell imaging
using the fluorescent nanoprobes is that the
fluorescence signal is easily affected by the back-
ground noises caused by the cells, matrix, and
the nonspecific scattering lights. The high signal
to noise (S/N) ratio is not easy to obtain.
d. Bioseparation. In a biomedical study, separa-
tion of specific biological entities (e.g., DNAs,
proteins, and cells) from their native environ-
ment is often required for analysis. Superpara-
magnetic colloids are ideal for this application
because of their on-off nature of magnetization
with and without an external magnetic field,
enabling the transportation of biomaterials with
am a g n e t i cf i e l d .I nat y p i c a lp r o c e d u r ef o r
separation, the biological entities are labeled by
superparamagnetic colloids and then subjected to
separation by an external magnetic field [92].
Nanometer-sized magnetic particles, such as
super paramagnetic iron oxide particles, have
been extensively used for separation and purifica-
tion of cells and biomolecules in bioprocesses
[93-95]. Due to their small size and high surface
area, MNPs have many superior characteristics
for these bioseparation applications compared to
those of the conventional micrometer-sized
resins or beads such as good dispersability, the
fast and effective binding of biomolecules, and
Figure 3 Schematic representation of the magnetically driven
transport of drugs to a specific region. A catheter is inserted into
an arterial feed to the tumor, and a magnetic stand is positioned
over the targeted site.
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the trends in this subject area is the magnetic
separation using antibodies to provide highly
accurate antibodies that can specifically bind to
their matching antigens on the surface of the tar-
geted species.
2. Catalysis applications. In recent years, catalysts
supported by MNPs have been extensively used to
improve the limitation of heterogeneous catalysis.
Magnetically driven, separations make the recovery
of catalysts in a liquid-phase reaction much easier
than using cross flow filtration and centrifugation,
especially when the catalysts are in the submicrom-
eter size range. Such small and magnetically separ-
able catalysts could combine the advantages of high
dispersion and reactivity with easy separation. In
terms of recycling expensive catalysts or ligands,
immobilization of these active species on MNPs
leads to the easy separation of catalysts in a quasi-
homogeneous system [96]. The various types of tran-
sition metal-catalyzed reactions using catalytic sites
grafted onto MNPs that have emerged recently
include carbon-carbon cross-coupling reactions,
hydroformylation [97], hydrogenation, and polymeri-
zation [98] reactions. Other reports on MNP-sup-
ported catalysts include enzymes for carboxylate
resolution, amino acids for ester hydrolysis, and
organic amine catalysts promoting Knoevenagel and
related reactions.
Environmental applications
A similarly important property of nanoscale iron parti-
cles is their huge flexibility for in situ applications. Mod-
ified iron nanoparticles, such as catalyzed and supported
nanoparticles, have been synthesized to further enhance
their speed and efficiency of remediation [99]. In spite
of some still unresolved uncertainties associated with
the application of iron nanoparticles, this material is
being accepted as a versatile tool for the remediation of
different types of contaminants in groundwater, soil, and
air on both the experimental and field scales [100]. In
recent years, other MNPs have been investigated for the
removal of organic and inorganic pollutants.
Organic pollutants
There are a few articles about the removal of high con-
centrations of organic compounds which are mostly
related to the removal of dyes. The MNPs have a high
capacity in the removal of high concentrations of
organic compounds [101-103]. Dyes are present in the
wastewater streams of many industrial sectors such as in
dyeing, textile factories, tanneries, and in the paint
industry. Therefore, the replacement of MNPs with an
expensive or low efficient adsorbent for treatment of
t e x t i l ee f f l u e n tc a nb eag o o dp l a t f o r mw h i c hn e e d s
more detailed investigations.
Inorganic pollutants
A very important aspect in metal toxin removal is the
preparation of functionalized sorbents for affinity or
selective removal of hazardous metal ions from compli-
cated matrices. MNPs are used as sorbents for the
removal of metal ions. Thus, MNPs show a high
[104-106] capacity and efficiency in the removal of dif-
ferent metal ions due to their high surface area with
respect to micron-sized sorbents. These findings can be
used to design an appropriate adsorption treatment plan
for the removal and recovery of metal ions from
wastewaters.
Analytical applications
1. Fluorescence techniques. Due to their small size,
magnetic luminescent NPs offer a larger surface
area-to-volume ratio than currently used microbe-
ads, which result in a good reaction homogeneity
and faster reaction kinetics. Thus, the preparation of
magnetic fluorescent particles, such as polystyrene
magnetic beads with entrapped organic dyes/quan-
tum dots [QDs] or shells of QDs [107], iron oxide
particles coated with dye-doped silica shells, and
silica NPs embedded with iron oxide and QDs, is
easier. However, their application is limited mostly
to biological applications, such as cellular imaging.
Only a few papers have reported the use of dual-
functional NPs for multiplexed quantitative bioanaly-
sis. The magnetic properties of the MLNPs allowed
their manipulation by an external magnetic field
without the need of centrifugation or filtration.
Their optical characteristics (sharp emission, photo-
stability, long lifetime) facilitated the implementation
of an internal calibration in the detection system.
This introduced a unique internal quality control
and easy quantifications in the multiplexed immu-
noanalysis. This method developed and enables a
direct, simple, and quantitative multiplex protein
analysis using conventional organic dyes and can be
applied for disease diagnostics and detection of bio-
logical threats.
1. Inorganic and hybrid coatings (or shells) on
colloidal templates have been prepared by preci-
pitation and surface reactions [108]. By adequate
selection of the experimental conditions, mainly
the nature of the precursors, temperature, and
pH, this method can give uniform, smooth coat-
ings, and therefore lead to monodispersed sphe-
rical composites. Using this technique,
submicrometer-sized anionic polystyrene lattices
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compounds [109] by aging at an elevated tem-
perature and by dispersions of the polymer col-
loid in the presence of aqueous solutions of
ferric chloride, urea, hydrochloric acid, and poly-
vinyl pyrrolidone. One of the most promising
techniques for the production of superparamag-
netic composites is the layer-by-layer self-assem-
bly method. This method was firstly developed
for the construction of ultrathin films [110] and
was further developed byC a r u s oe ta l .[ 1 1 1 ]f o r
the controlled synthesis of novel nanocomposite
core-shell materials and hollow capsules. It con-
sists of the stepwise adsorption of charged poly-
mers or nanocolloids and oppositely charged
polyelectrolytes onto flat surfaces or colloidal
templates, exploiting primarily electrostatic inter-
actions for layer buildup. Using this strategy, col-
loidal particles have been coated with alternating
layers of polyelectrolytes, nanoparticles, and pro-
teins [112]. Furthermore, Caruso et al. have
demonstrated that submicrometer-sized hollow
silica spheres or polymer capsules can be
obtained after removal of the template from the
solid-core multilayered-shell particles either by
calcination or by chemical extraction. Their work
in the preparation of iron oxide superparamag-
netic and monodisperse, dense, and hollow sphe-
rical particles that could be used for biomedical
applications deserves special mention.
2. Encapsulation of magnetic nanoparticles in
polymeric matrixes. Encapsulation of inorganic
particles into organic polymers endows the parti-
cles with important properties that bare
uncoated particles lack [113]. Polymer coatings
on particles enhance compatibility with organic
ingredients, reduce susceptibility to leaching, and
protect particle surfaces from oxidation. Conse-
quently, encapsulation improves dispersibility,
chemical stability, and reduces toxicity [114].
Polymer-coated magnetite nanoparticles have
been synthesized by seed precipitation polymeri-
zation of methacrylic acid and hydroxyethyl
methacrylate in the presence of the magnetite
nanoparticles [115]. Cross-linking of polymers
h a sa l s ob e e nr e p o r t e da sa na d e q u a t em e t h o d
for the encapsulation of magnetic nanoparticles.
To prepare the composites by this method, first,
mechanical energy needs to be supplied to create
a dispersion of magnetite in the presence of aqu-
eous albumin [116], chitosan [117], or PVA poly-
mers [118]. More energy creates an emulsion of
the magnetic particle sol in cottonseed [119],
mineral [120], or vegetable oil [121]. Depending
upon composition and reaction conditions, the
addition of a cross-linker and heat results in a
polydispersed magnetic latex, 0.3 microns in dia-
meter, with up to 24 wt.% in magnetite content
[122]. Recently, the preparation of superparamag-
netic latex via inverse emulsion polymerization
has been reported [123]. A ‘double-hydrophilic’
diblock copolymer, present during the precipita-
tion of magnetic iron oxide, directs nucleation,
controls growth, and sterically stabilizes the
resulting 5-nm superparamagnetic iron oxide.
After drying, the coated particles repeptize creat-
ing a ferrofluid-like dispersion. Inverse emulsifi-
cation of the ferrofluid into decane, aided by
small amounts of diblock copolymer emulsifier
along with ultrasonication, creates mini droplets
(180 nm) filled with magnetic particles and
monomer. Subsequent polymerization generates
magnetic latex. A novel approach to prepare
superparamagnetic polymeric nanoparticles by
synthesis of the magnetite core and polymeric
shell in a single inverse microemulsion was
reported by Chu et al. [124]. Stable magnetic
nanoparticle dispersions with narrow size distri-
bution were thus produced. The microemulsion
seed copolymerization of methacrylic acid,
hydroxyethyl methacrylate, and cross-linker
resulted in a stable hydrophilic polymeric shell
around the nanoparticles. Changing the mono-
mer concentration and water/surfactant ratio
controls the particle size.
Encapsulation of magnetic nanoparticles in inorganic
matrixes. An appropriate tuning of the magnetic proper-
ties is essential for the potential use of the superpara-
magnetic composites. In this way, the use of inorganic
matrixes, in particular of silica, as dispersion media of
superparamagnetic nanocrystals has been reported to be
an effective way to modulate the magnetic properties by
a simple heating process [125]. Another advantage of
having a surface enriched in silica is the presence of sur-
face silanol groups that can easily react with alcohols
and silane coupling agents [126] to produce dispersions
that are not only stable in nonaqueous solvents, but also
provide the ideal anchorage for covalent bonding of spe-
cific ligands. The strong binding makes desorption of
these ligands a difficult task. In addition, the silica sur-
face confers a high stability to suspensions of the parti-
cles at high volume fractions, changes in pH, or
electrolyte concentration [127]. Recently, we have been
successful in preparing submicronic silica-coated
maghemite hollow and dense spheres with a high load-
ing of magnetic material by aerosol pyrolysis [128].
Silica-coated g-Fe2O3 hollow spherical particles with an
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sis of methanol solutions containing iron ammonium
citrate and tetraethoxysilane [TEOS] at a total salt con-
centration of 0.25 M [129]. During the first stage, the
rapid evaporation of the methanol solvent favors the
surface precipitation (i.e., formation of hollow spheres)
of the components [130]. The low solubility of the iron
ammonium citrate in methanol when compared with
that of TEOS promotes the initial precipitation of the
iron salt solid shell. During the second stage, the prob-
able continuous shrinkage of this iron salt solid shell
facilitates the enrichment at the surface of the silicon
oxide precursor (TEOS). In the third stage, the thermal
decomposition of precursors produces the silica-coated
g-Fe2O3 hollow spheres. The formation of the g-Fe2O3 is
associated with the presence of carbonaceous species
coming from the decomposition of the methanol solvent
and from the iron ammonium citrate and TEOS. On the
other hand, the aerosol pyrolysis of iron nitrate and
TEOS at a total salt concentration of 1 M produced
silica-coated g-Fe2O3 dense spherical particles with an
average size of 250 nm. The increase in salt concentra-
tion to a value of 1 M favors the formation of dense
spherical particles. Sedimentation studies of these parti-
cles have shown that they are particularly useful for
separation applications [131]. A W/O microemulsion
method has also been used for the preparation of silica-
coated iron oxide nanoparticles [132]. Three different
non-ionic surfactants (Triton X-100, Dow Chemical
Company, Midland, MI, USA; Igepal CO-520, and Brij-
97) have been used for the preparation of microemul-
sions, and their effects on the particle size, crystallinity,
and the magnetic properties have been studied
3. The iron oxide nanoparticles are formed by
the coprecipitation reaction of ferrous and ferric
salts with inorganic bases. A strong base, NaOH,
and a comparatively mild base, NH4OH, have
been used with each surfactant to observe
whether the basicity influences the crystallization
process during particle formation. All these sys-
tems show magnetic behavior close to that of
superparamagnetic materials. By using this
method, magnetic nanoparticles as small as 1 to
2n ma n do fv e r yu n i f o r ms i z e( s t a n d a r dd e v i a -
tion less than 10%) have been synthesized. A uni-
form silica coating as thin as 1 nm encapsulating
the bare nanoparticles is formed by the base-cat-
alyzed hydrolysis and the polymerization reaction
of TEOS in the microemulsion. It is worth men-
tioning that the small particle size of the compo-
site renders these particles a potential candidate
for their use in in vivo applications.
Size selection methods
Biomedical applications likem a g n e t i cr e s o n a n c ei m a -
ging, magnetic cell separation, or magnetorelaxometry
control the magnetic properties of the nanoparticles in
magnetic fluids. Furthermore, these applications also
depend on the hydrodynamic size. Therefore, in many
cases, only a small portion of particles contributes to
the desired effect. The relative amount of the particles
with the desired properties can be increased by the
fractionation of magnetic fluids [133]. Common meth-
ods currently used for the fractionation of magnetic
fluids are centrifugation [134] and size-exclusion chro-
matography [135]. All these methods separate the par-
ticles via nonmagnetic properties like density or size.
Massart et al [136] have proposed a size sorting proce-
dure based on the thermodynamic properties of aqu-
eous dispersions of nanoparticles. The positive charge
of the maghemite surface allows its dispersion in aqu-
eous acidic solutions and the production of dispersions
stabilized through electrostatic repulsions. By increas-
ing the acid concentration (in the range 0.1 to 0.5 mol
l-1), interparticle repulsions are screened, and phase
transitions are induced. Using this principle, these
authors describe a two-step size sorting process in
order to obtain significant amounts of nanometric
monosized particles with diameters between typically 6
and 13 nm. As the surface of the latter is not modified
by the size sorting process, usual procedures are used
to disperse them in several aqueous or oil-based
media. Preference should be given, however, to parti-
tions based on the properties of interest, in this case,
the magnetic properties. So far, magnetic methods
have been used only for the separation of magnetic
fluids, for example, to remove aggregates by magnetic
filtration [137]. Recently, the fractionation of magnetic
nanoparticles by flow field-flow fractionation was
reported [138]. Field-flow fractionation is a family of
analytical separation techniques [139,140], in which the
separation is carried out in a flow with a parabolic
profile running through a thin channel. An external
field is applied at a right angle to force the particles
toward the so-called accumulation wall [141,142].
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